The drugs were effective in reducing mtDNA instability in the heteroallelic AAC2/aac2Met114Pro strain and also in heteroallelic strain carrying the Arg96His mutation equivalent to the dominant to ANT1 Arg80His mutation associated with mitochondrial disease (OMIM 617184) [94]. The gene discussed is SLC25A4; the disease is inborn mitochondrial metabolism disorder.